Therefore, FSTL1 may be critical in promoting angiogenesis in ischemic diseases by regulating blood glucose, VEGF, and cell matrix synthesis, which can all improve the symptoms and prognosis of ischemic diseases. The gene discussed is FSTL1; the disease is ischemic disease.